ALLIAR (AALR3) Main Indicators
Basic Data - AALR3
| Company | ALLIAR |
| Corporate Name | ALLIANÇA SAÚDE E PARTICIPAÇÕES S.A. |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Novo Mercado |
| Activity | Prestação de serviços de medicina diagnóstica |
| Share | AALR3 |
| Quote Date | 11/19/2024 |
| Share Type | ON |
| Last Closing | R$ 13.48 |
| Quotation Factor | 1 Share |
| Financial Volume | R$ 254.91 thousand |
| Last Statement | ITR - 09/30/2024 |
| Sector | Saúde |
| Subsector | Serv.Méd.Hospit..Análises e Diagnósticos |
| Segment | Serv.Méd.Hospit..Análises e Diagnósticos |
| Participation Indexes | IGC, IGNM, ITAG |
| Updated 11/21/2024 | |
Relative Prices - AALR3
| Price/Earnings | -9.67 |
| Price/SBV | 1.39 |
| Price/Net Sales | 1.32 |
| Price/CFO | 8.10 |
| Price/FCF | 14.96 |
| Price/Total Assets | 0.60 |
| Price/EBIT | 24.21 |
| Price/Working Capital | -10.99 |
| Price/NCAV | -0.98 |
| EV/EBIT | 32.83 |
| EV/EBITDA | 12.49 |
| EV/Net Sales | 1.79 |
| EV/CFO | 10.98 |
| EV/FCF | 20.28 |
| EV/Total Assets | 0.82 |
| Company Market Cap | R$ 1.59 B |
| Enterprise Value | R$ 2.16 B |
| Current Financial Statement Date | 09/30/2024 |
| Current Share Price | R$ 13.48 |
| Share Price Date | 11/19/2024 |
| Dividend Yield | 0.00% |
| Updated 11/21/2024 | |
Income Statement - AALR3
| Net Revenue | R$ 1.20 B |
| Gross Result | R$ 365.86 M |
| EBIT | R$ 65.86 M |
| Depreciation and Amortization | - R$ 107.28 M |
| EBITDA | R$ 173.14 M |
| Net Profit | - R$ 164.87 M |
| Net Profit/Share | - R$ 1.39 |
| Updated 11/18/2024 | |
| Net Revenue | R$ 317.88 M |
| Gross Result | R$ 99.43 M |
| EBIT | R$ 44.57 M |
| Depreciation and Amortization | - R$ 26.60 M |
| EBITDA | R$ 71.17 M |
| Net Profit | R$ 1.80 M |
| Profit/Share | R$ 0.02 |
| Updated 11/18/2024 | |
Price and Volume Behavior - AALR3
| Lowest Price 52 weeks | R$ 6.19 |
| Highest Price 52 weeks | R$ 17.07 |
| Variation 2024 | 58.59% |
| Variation 1 year | 26.34% |
| Variation 2 years(total) | -34.56% |
| Variation 2 years(yearly) | -19.06% |
| Variation 3 years(total) | -20.80% |
| Variation 3 years(yearly) | -7.47% |
| Variation 4 years(total) | 25.51% |
| Variation 4 years(yearly) | 5.85% |
| Variation 5 years(total) | -26.93% |
| Variation 5 years(yearly) | -6.07% |
| Average Daily Volume (3 months) | R$ 370.95 thousand |
| Updated 11/21/2024 | |
Returns and Margins - AALR3
| Return on Initial Tangible Capital | 3.86% |
| Return on Initial Invested Capital | 2.45% |
| Pre-Tax Return on Initial Tangible Capital | 5.85% |
| Pre-Tax Return on Initial Invested Capital | 3.72% |
| Return on Initial Shareholder´s Equity | -16.24% |
| Return on Initial Asset | -6.00% |
| Gross Margin | 30.37% |
| Net Margin | -13.69% |
| EBIT Margin | 5.47% |
| EBITDA Margin | 14.37% |
| Initial Asset Turnover | 0.44 |
| Financial Leverage | 2.30 |
| Liabilities/Net Worth | 1.30 |
| Net Debt/EBITDA | 3.28 |
| Updated 11/18/2024 | |
Balance Sheet - AALR3
| Cash and Cash Equivalents | R$ 167.70 M |
| Total Assets | R$ 2.64 B |
| Short-Term Debt | R$ 240.38 M |
| Long-Term Debt | R$ 494.59 M |
| Gross Debt | R$ 734.97 M |
| Net Debt | R$ 567.27 M |
| Shareholder´s Equity | R$ 1.15 B |
| Share Book Value | R$ 9.70 |
| Common Shares | 118,292,816 |
| Preferred Shares | 0 |
| Total | 118,292,816 |
| Common Shares in Treasury | 90,827 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 90,827 |
| Common Shares (Except Treasury) | 118,201,989 |
| Preferred Shares (Except Treasury) | 0 |
| Total (Except Treasury) | 118,201,989 |
| Updated 11/18/2024 | |
Cash Flow - AALR3
| Operating Cash Flow | R$ 196.96 M |
| Cash Flow from Investments | - R$ 128.53 M |
| Financing Cash Flow | - R$ 195.34 M |
| Increase (Reduction) in Cash and Equivalents | - R$ 126.91 M |
| Updated 11/18/2024 | |
| Operating Cash Flow | R$ 47.26 M |
| Cash Flow from Investments | - R$ 43.99 M |
| Financing Cash Flow | - R$ 90.05 M |
| Increase (Reduction) in Cash and Equivalents | - R$ 86.78 M |
| Updated 11/18/2024 | |
Experimental - AALR3
| CAPEX 3 months | - R$ 30.10 M |
| Free Cash Flow 3 months | R$ 17.16 M |
| CAPEX 12 months | - R$ 90.37 M |
| Free Cash Flow 12 months | R$ 106.59 M |
| Updated 11/18/2024 | |